SDMHF Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Sartorius Stedim Biotech SA

Watchlist Manager

Watchlist

Price: 244 USD Market Closed

Market Cap: $23.7B

	Sartorius Stedim Biotech SA OTC:SDMHF	FR
M	Marinomed Biotech AG VSE:MARI	AT
S	Sds Optic SA WSE:SDS	PL
C	Conygar Investment Co PLC LSE:CIC	UK
	Shanghai Bright Meat Group Co Ltd SSE:600073	CN
E	Endesa SA XMUN:ENA	ES
A	American Eagle Outfitters Inc F:AFG	US
	Sunrun Inc NASDAQ:RUN	US
	Healthcare Realty Trust Inc NYSE:HR	US
	Wickes Group PLC LSE:WIX	UK

Profitability Summary

Sartorius Stedim Biotech SA's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

45%

Sustainable 3Y Average Gross Margin

44%

Declining Gross Margin

49% > 45%

Healthy Operating Margin

19%

Sustainable 3Y Average Operating Margin

16%

Declining Operating Margin

19% > 19%

Low Net Margin

10%

Low 3Y Average Net Margin

Declining Net Margin

15% > 10%

Exceptional Free Cash Flow Margin

13%

Strong 3Y Average Free Cash Flow Margin

13%

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.